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ABSTRACT The type VI secretion system (T6SS) is a widespread secretory apparatus produced by Gram-negative bacteria that
has emerged as a potent mediator of antibacterial activity during interbacterial interactions. Most Acinetobacter species produce
a genetically conserved T6SS, although the expression and functionality of this system vary among different strains. Some patho-
genic Acinetobacter baumannii strains activate this secretion system via the spontaneous loss of a plasmid carrying T6SS repres-
sors. In this work, we compared the expression of T6SS-related genes via transcriptome sequencing and differential proteomics
in cells with and without the plasmid. This approach, together with the mutational analysis of the T6SS clusters, led to the deter-
mination of the genetic components required to elaborate a functional T6SS in the nosocomial pathogen A. baumannii and the
nonpathogen A. baylyi. By constructing a comprehensive combination of mutants with changes in the T6SS-associated vgrG
genes, we delineated their relative contributions to T6SS function.We further determined the importance of two effectors, in-
cluding an effector-immunity pair, for antibacterial activity. Our genetic analysis led to the identification of an essential
membrane-associated structural component named TagX, which we have characterized as a peptidoglycan hydrolase possessing
L,D-endopeptidase activity. TagX shows homology to known bacteriophage L,D-endopeptidases and is conserved in the T6SS
clusters of several bacterial species. We propose that TagX is the first identified enzyme that fulfills the important role of en-
abling the transit of T6SS machinery across the peptidoglycan layer of the T6SS-producing bacterium.
IMPORTANCE Acinetobacter baumannii is one of the most troublesome and least investigated multidrug-resistant bacterial
pathogens. We have previously shown that A. baumannii employs a T6SS to eliminate competing bacteria. Here we provide a
comprehensive analysis of the components of the T6SS of Acinetobacter, and our results provide genetic and functional insights
into the Acinetobacter T6SS. Through this analysis, we identified a novel peptidoglycan hydrolase, TagX, that is required for bio-
genesis of the T6SS apparatus. This is the first peptidoglycanase specialized in T6SS function identified in any species. We pro-
pose that this enzyme is required for the spatially and temporally regulated digestion of peptidoglycan to allow assembly of the
T6SSmachinery.
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While many species of Acinetobacter, a genus of Gram-negative bacteria of the class Gammaproteobacteria, are
commonly cultivated from environments such as soil and water,
several Acinetobacter species are important opportunistic patho-
gens (1). The most clinically relevant member of the genus, Acin-
etobacter baumannii, is rarely isolated outside the hospital setting
and is a major health care threat because of extensive drug resis-
tance (2, 3). Environmental and pathogenic strains of Acinetobac-
ter species are likely to encounter and interact with other mi-
crobes. The factors mediating such interactions are not well
known, although cross-kingdom signaling has been shown to af-
fect the outcome of A. baumannii interactions with some eu-
karyotes (4). Furthermore, the ability to withstand desiccation
and form biofilms may contribute to Acinetobacter species persis-
tence under hostile conditions in their various niches (5–7). The
multitude of molecular structures present on the cell surface con-
tribute in a variety of ways to the survival and pathogenicity of
these organisms (8).
Secretion systems of Gram-negative bacteria are diverse in
terms of both the structural components used to assemble the
secretion system and the proteins exported by each apparatus.
Among the different secretory systems employed by Gram-
negative bacteria, the type VI secretion system (T6SS) has
emerged as a widespread mechanism for protein export (9–11).
The T6SS delivers effector proteins to both bacterial and eukary-
otic cells in a contact-dependentmanner, with the exported toxins
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harboring enzymatic activity deleterious to the target cell (12).
There exists a significant diversity in the effector repertoires of
T6SS-containing organisms, and delivery depends on the assem-
bly of a core set of 13 conserved T6SS genes (9), called tss genes, as
well as a variable number of T6SS-associated genes (tag genes),
that are accessory components that often contribute to regulation.
ManyT6SS components resemble bacteriophage proteins, leading
to models in which the T6SS apparatus mimics an inverted bacte-
riophage that assembles in the cytoplasm and contracts, eventu-
ally releasing its cargo (13). Indeed, structural and functional
studies have provided support for this model (14, 15). In addition
to secretion of effector proteins, contraction of the T6SS also leads
to the export of twohallmark proteins,Hcp andVgrG.Hcp, one of
the main components secreted by all functional T6SSs (16), as-
sembles as a hexamer and bears similarity to phage  tail protein
gpV (11, 14, 17). Detection of secreted Hcp in culture superna-
tants is a well-established molecular marker of a functional T6SS
(16). VgrG proteins are similar to the complex formed by gp27/
gp5 of T4 phage (17) and can contain effector activity in extended
C-terminal domains (18). Although Hcp and VgrG are often
codependent for secretion and required for T6SS activity,multiple
similar VgrG proteins are usually possessed by a single organism
and eachmay not be essential forHcp secretion (18–21). Recently,
Hcp and VgrG have been shown to be necessary for distinct effec-
tor export pathways (22).Hcp can interact with effector substrates
via the internal residues of its ring-shaped structure (23), and
PAAR domain-containing proteins can interact with the tip of
someVgrG trimers (24). Furthermore, genes for effectors are usu-
ally located near vgrG genes that are essential for the secretion of
the effectors (25). These effectors may interact directly with the
cognate VgrG or utilize adaptor proteins to facilitate their secre-
tion (25–28). Other important components include the TssB and
TssC proteins, which assemble cytoplasmic structures resembling
a bacteriophage sheath (29) and change rapidly between extended
and contracted states (13). The sheath formed by TssB/TssC,
which requires the gp25-like baseplate protein TssE for assembly
(13, 30), may physically accommodate the Hcp tubule (31) and is
recycled by another essential T6SS component, ClpV (TssH),
upon contraction (29). Mutagenesis and functional studies have
confirmed the importance of the remaining T6SS components for
apparatus function (32, 33), including a membrane complex and
other essential structural elements (20, 34–36). Structures span-
ning the bacterial cell wall, for example, flagella and T3SSs, often
require dedicated peptidoglycan (PG)-remodeling enzymes for
their assembly (37). Despite the tremendous advances in our un-
derstanding of T6SS biogenesis in the past decade, it remains to be
determined how this secretory system passes through the PG layer
of the T6SS-producing organism.
It has recently come to be appreciated that many Acinetobacter
species possess an antibacterial T6SS (38–42). However, individ-
ual strains vary in the expression of the T6SS,with some exhibiting
robust T6SS activity and others possessing an apparently inactive
system (38, 41, 42). The T6SS of several A. baumannii strains is
controlled by plasmid-encoded regulators, and multidrug-
resistant strains generally do not show T6SS activity under labo-
ratory conditions (41, 42). Bioinformatic analysis has suggested
that the core T6SS components of Acinetobacter species are en-
coded by genes in a single conserved locus, with vgrG genes being
distributed in various numbers throughout the genome (38, 43,
44). While the tssM, tssB, and hcp genes have been mutated and
confirmed as essential for T6SS activity in Acinetobacter, the re-
maining genes in the T6SS cluster, as well as the vgrG genes, have
not been experimentally tested for their contributions to the T6SS
(38, 39, 41).
In this work, we analyzed the genetic requirements for the elab-
oration of a functional T6SS in Acinetobacter species. Further-
more, we evaluated the contributions of VgrG proteins and effec-
tors to apparatus function and antibacterial activity. Finally, we
describe a novel structural component of the T6SS, a PG-
degrading enzyme we have termed TagX. We found that this en-
zyme is conserved across several genera and is essential for extra-
cellular export of Hcp. We propose that TagX, by functioning as
an L,D-endopeptidase, performs the essential enzymatic step of
cell wall degradation, allowing transit of the T6SS tubule.
RESULTS
Transcriptomic and genetic analyses reveal novel genes re-
quired for the Acinetobacter T6SS. While the proteins required
for assembly and function of the T6SS have been investigated in
detail in some bacteria, little is known about the requirements for
theAcinetobacter T6SS.We recently described a novel mechanism
of T6SS regulation possessed by several strains of A. baumannii
(42). In these strains, plasmid-encoded regulators repressed the
chromosomally encoded T6SS. Upon spontaneous plasmid loss,
and therefore loss of the repressors, the T6SS was activated and
functioned as an antibacterial apparatus. However, the precise
transcriptional changes that occurred upon plasmid loss were not
investigated. We used transcriptome sequencing (RNA-seq) to
probe the changes in gene expression betweenplasmid-containing
(T6) and plasmidless (T6) A. baumannii ATCC 17978 cells in
order to define the components required for a functional T6SS.
These transcriptomic data revealed the genes in the previously
predicted T6SS cluster that were upregulated in T6 cells (Ta-
ble 1). The transcriptomic changes were significant, with up to
nearly 50-fold upregulation of some genes. Furthermore, distantly
located vgrG gene clusters also showed significant changes in their
transcriptional profile. We then confirmed these changes at the
protein level by a whole-cell differential proteomic approach (Ta-
ble 1). Of the 21 genes identified as statistically significantly dif-
ferentially expressed by RNA-seq in the main T6SS cluster, we
identified and quantified, on the basis of at least two unique pep-
tides, 18 of these proteins, all of which were statistically signifi-
cantly different between T6 and T6 cells. These data prompted
us to genetically dissect the contributions of these proteins to the
assembly of the Acinetobacter T6SS.
Recently, a complete collection of null mutants of nonpatho-
genic A. baylyi ADP1 was constructed that included genes that
encode proteins expected to be involved in T6SS apparatus assem-
bly and activity (43).A. baylyiADP1 possesses a T6SS that secretes
the conserved Hcp protein under standard laboratory growth
conditions (38), and it was previously demonstrated that this se-
cretion system contributes to antibacterial activity against Esche-
richia coli (40). Furthermore, the genes in this cluster are highly
conserved across all T6SS-producing Acinetobacter species (38).
Using our transcriptomic data as a guide, we tested several mu-
tants with changes within and surrounding the predicted T6SS
cluster for ADP1T6SS function (Fig. 1A). Hcp secretionwas abol-
ished in 14 of the mutants with changes that clustered in a
15-gene tract from ACIAD2684 to ACIAD2699 (Fig. 1B), and
this confirms that this cluster comprises the core T6SS genes in
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this organism. The tagN (ACIAD2682), tagF (ACIAD2683),
and ACIAD2698 mutants secreted Hcp to a greater extent than
the wild type did.While ACIAD2698 has no homologs outside the
genus Acinetobacter, TagN contains a PG binding domain and is
present in Burkholderia T6SS-1 (45) and TagF is a repressor of the
Pseudomonas aeruginosa H1 T6SS (46).
Excluding the hcp mutant itself, most of the mutant strains
expressed levels of Hcp comparable to those of wild-type ADP1
when analyzed by Western blotting, indicating that a lack of ex-
pression was not a factor in the loss of Hcp secretion (Fig. 1B).
However, tssB and tssCmutants expressed a detectably lower level
of Hcp, which could account for the loss of Hcp secretion. As tssB
and tssC are located upstreamof hcp, it is possible thatmutation of
these genes affected the downstream expression of hcp. However,
the tssB and tssC genes are both essential forHcp secretion in other
bacteria (32). ACIAD2685, ACIAD2693, and ACIAD2699 do not
TABLE 1 Transcriptomic and differential proteomic analyses of T6SS and VgrG clusters in T6 and T6 A. baumannii ATCC 17978



























ACX60_11600 tagX 37.2 (3.2) 3.4 (1.0) 3.1 (3.3E-28) 8.3 ACIAD2699 NaNd NaN
ACX60_11605 Hypothetical 63.0 (17.0) 2.7 (0.5) 4.0 (2.8E-32) 15.5 ACIAD2698 1.8 (0.00041) 3 (22.204)
ACX60_11610 tssL 91.3 (18.4) 4.5 (2.1) 3.9 (6.5E-46) 14.7 ACIAD2697 1.2 (0.028232) 1 (2.4722)
ACX60_11615 tssK 259.6 (14.1) 10.8 (1.6) 4.3 (7.8E-158) 19.8 ACIAD2696 1.7 (0.011007) 6 (76.533)
ACX60_11620 tssA 221.9 (26.5) 5.2 (0.8) 5.0 (3.8E-134) 32.8 ACIAD2695 2.6 (0.001157) 5 (21.411)
ACX60_11625 clpV 258.7 (8.6) 23.1 (2.0) 3.3 (4.8E-144 9.5 ACIAD2694 2.5 (0.002065) 35 (323.31)
ACX60_11630 PAAR 39.2 (15.7) 5.0 (0.9) 2.3 (8.0E-08) 5.1 ACIAD2681 0.9 (0.066403) 1 (12.532)
ACX60_11635 tagN 99.4 (9.3) 8.9 (1.5) 3.2 (1.9E-48) 9.0 ACIAD2682 1.5 (0.004644) 6 (54.441)
ACX60_11640 tagF 44.4 (12.6) 3.3 (0.8) 3.3 (2.6E-28) 9.9 ACIAD2683 1.7 (0.005088) 4 (22.213)
ACX60_11645 tssM 320.3 (16.8) 23.3 (0.8) 3.5 (3.2E-194) 11.7 ACIAD2684 1.8 (0.029757) 35 (323.31)
ACX60_11650 Hypothetical 89.3 (13.9) 4.1 (1.2) 4.1 (6.8E-72) 17.1 ACIAD2685 1.2 (0.000429) 2 (28.15)
ACX60_11655 tssG 179.8 (32.2) 4.5 (0.3) 4.9 (3.2E-99) 30.1 ACIAD2686 1.4 (0.000083) 2 (4.6976)
ACX60_11660 tssF 134.9 (28.3) 4.5 (0.5) 4.6 (1.1E-103) 23.5 ACIAD2687 2.7 (0.018475) 4 (23.9)
ACX60_11665 tssE 1078.5 (165.7) 30.2 (2.3) 4.8 (3.2E-167) 28.7 ACIAD2688 NaN NaN
ACX60_11670 hcp 11801.2 (588.2) 198.8 (18.9) 5.6 (0) 49.4 ACIAD2689 2.8 (0.000359) 11 (139.41)
ACX60_11675 tssC 1823.6 (258.4) 30.5 (1.6) 5.6 (0) 49.0 ACIAD2690 2.7 (0.000598) 23 (323.31)
ACX60_11680 tssB 1516.7 (145.5) 34.7 (7.8) 5.1 (3.3E-206) 35.2 ACIAD2691 3.1 (0.000546) 14 (253.32)
ACX60_11685 Hypothetical 545.2 (6.2) 9.3 (0.6) 5.5 (8.2E-202) 46.3 ACIAD2693 2.7 (0.001271) 9 (235.49)
ACX60_11690 Hypothetical 600.3 (50.0) 125.4 (19.9) 2.0 (8.7E-43) 4.0 ACIAD3112/3113 1.1 (0.002987) 18 (321.94)
ACX60_11695 tse3 effector 167.0 (37.0) 14.6 (0.2) 3.2 (2.6E-77) 9.5 ACIAD3114 NaN NaN
ACX60_11700 vgrG3 96.3 (10.7) 47.8 (1.4) 0.8 (1.2E-08) 1.8 ACIAD3115 1.2 (0.013778) 13 (1.2162)
ACX60_11705 Hypothetical 6.0 (2.3) 2.7 (0.6) 0.7 (3.0E-01) 1.6 None 0.1 (0.646629) 1 (1.8381)
VgrG1 cluster
ACX60_17640 Hypothetical 16.2 (3.2) 3.4 (2.3) 1.7 (2.8E-4) 3.2 None NaN NaN
ACX60_17645 Hypothetical 9.6 (40) 0.4 (0.4) 2.6 (7.9E-6) 6.0 None NaN NaN
ACX60_17650 Hypothetical 34.8 (12.5) 1.5 (1.0) 3.5 (4.8E-15) 11.6 None NaN NaN
ACX60_17655 Hypothetical 37.6 (5.3) 2.0 (1.2) 3.5 (3.8E-19) 11.1 None 1.7 (0.010153) 7 (67.368)
ACX60_17660 tse1 328.8 (53.3) 12.0 (1.7) 4.4 (2.0E-117) 21.6 None 2.3 (0.003947) 1 (1.6312)
ACX60_17665 vgrG1 203.4 (27.4) 36.5 (1.0) 2.2 (9.11E-59) 4.8 Multiple vgrG genes 2.4 (0.011138) 16 (222.15)
ACX60_17670 Hypothetical 6.7 (2.9) 1.4 (0.3) 1.6 (2.7E-3) 3.0 None NaN NaN
VgrG2 cluster
ACX60_15360 tsi2 (tdi) 192.3 (17.0) 103.2 (2.9) 0.7 (2.3E-7) 1.6 None 0.1 (0.350265) 9 (114.72)
ACX60_15365 tse2 (tde) 158.9 (17.2) 64.0 (3.3) 1.1 (1.8E-15) 2.1 None 0.4 (0.135599) 8 (65.825)
ACX60_15370 vgrG2 143.1 (15.3) 200.4 (13.8) 0.7 (2.7E-7) 1.6 Multiple vgrG genes 1.0 (0.049891) 12 (33.815)
VgrG4 cluster
ACX60_00585 vgrG4 65.5 (9.4) 23.2 (2.6) 1.3 2.4 Multiple vgrG genes NaN NaN
ACX60_00590 Hypothetical 1.3 (0.2) 3.9 (0.1) 0.7 1.6 None NaN NaN
ACX60_00595 Hypothetical 1.8 (1.8) 6.2 (4.1) 0.3 1.2 None NaN NaN
ACX60_00600 Hypothetical 0.4 (0.7) 0.0 (0.0) 0.2 1.1 None NaN NaN
ACX60_00605 tse4 (tae) 13.0 (1.6) 8.2 (2.1) 0.5 1.4 None NaN NaN
ACX60_00610 tsi4 19.2 (8.6) 8.8 (3.1) 0.8 1.8 None 0.2 (0.283492) 10 (105.54)
ACX60_00615 Hypothetical 5.4 (0.7) 3.2 (1.4) 0.5 1.4 None NaN NaN
a Data shown are mean values (standard deviations) of three biological replicate samples.
b Between T6 and T6.
c Statistical significance was tested by using DESEq2.
d NaN, not detected.
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have characterized homologs in other T6SS-producing organ-
isms, indicating that they represent novel genetic components of
the Acinetobacter T6SS. ACIAD2685 is predicted to encode a
membrane protein, and ACIAD2693 is predicted to encode a sig-
nal peptide and therefore probably functions in the periplasm.
The protein encoded by ACIAD2699 is predicted to contain a
C-terminal peptidase domain (pfam13539) similar to the PG-
cleaving VanY peptidase superfamily of proteins but does not re-
semble any known T6SS components.
These results establish the core components of the T6SS of
A. baylyi ADP1 and, considering their conserved nature in this
genus (38), offer insight into necessary T6SS components in other
Acinetobacter species.
Establishing the contribution of VgrG proteins to apparatus
formation and bacterial killing identifies important antibacte-
rial effectors. VgrG proteins are secreted T6SS components that
can be essential for forming a functional T6SS but also play a role
in the secretion of other components (10, 24, 25). These proteins
can mediate the secretion of effectors encoded downstream or
have effector functions in extended C-terminal domains (16, 18,
25). The number of vgrG genes possessed by Acinetobacter species
varies but is generally between two and four (Fig. 2) (38). A. bau-
mannii ATCC 17978 contains four VgrG proteins (VgrG1 to -4),
none of which contains an identifiable effector domain. However,
near each vgrG gene is a gene for a putative effector, suggesting
that these VgrG proteins act as adaptors for the secretion of cog-
nate effectors (Fig. 2). Indeed, all of the VgrG proteins in A. bau-
mannii ATCC 17978 contain a C-terminal DUF2345 domain that
has been shown to play a role in stabilizing VgrG-effector interac-
tions (28). Our bioinformatic analysis indicated that A. bauman-
nii possesses a diverse repertoire of effectors encoded by vgrG clus-
ters, with some seemingly susceptible to transposase integration
(e.g., strain AYE) (Fig. 2). The predicted effector downstream of
A. baumannii ATCC 17978 vgrG1 contains domains associated
with lipases, and several type VI lipase effectors (Tle) have been
previously shown to target lipidic substrates accessible from
FIG 1 (A) Genetic organization of the T6SS locus in A. baylyi ADP1. Locus numbers are indicated at the top, and relevant T6SS nomenclature is shown at the
bottom. Genes in red are essential for Hcp secretion, and those in black are not essential or act to enhance secretion. Genes in gray were not tested. (B) Western
blot assays probing for Hcp expression and secretion in whole-cell pellets (P) or supernatants (S) of theA. baylyiADP1 strains indicated. Numbers represent the
ACIAD gene numbers. RNA polymerase (RNAP) was used as a loading and lysis control. WT, wild type.
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the periplasm, with cognate immunity proteins located in the
periplasm (47). Furthermore, this putative effector contains a
GXSXGmotif typical of some Tle family members (47). This sug-
gests that the enzyme encoded by a gene downstream of vgrG1 is a
Tle, and immunity would be due to a protein encoded by a nearby
gene. Immunity proteins are typically more difficult to predict in
silico; however, the protein of unknown function encoded by
ACX60_17670 contains a signal peptide directing it to the
periplasm, which is the expected site of Tle activity (Fig. 2). The
predicted effector encoded by a gene near vgrG2 contains a nu-
clease domain, and the downstream immunity protein contains a
GAD-like domain and a DUF1851 domain. A similar nuclease
(type VI DNase effector, Tde) and immunity pair were found in
Agrobacterium tumefaciens, with the Tde effector being delivered
in a T6SS-dependent manner (48). Indeed, those authors bioin-
formatically identified this A. baumannii effector as a member of
the Tde superfamily containing the requisite HXXD catalytic mo-
tif. The predicted effector protein in the vgrG3 cluster did not
show homology to any known effector domains, but our experi-
mental data suggest that it plays an important role in bacterial
killing. While T6SS effectors are generally named on the basis of
their characterized biochemical activity, in the absence of such
data, we have tentatively named this gene tse (type six effector).
The effector downstream of vgrG4 contains a LysM PG binding
FIG 2 Schematic of the vgrG clusters present in selected A. baumannii strains. The vgrG genes are blue, the putative tse effectors are red, and the tsi immunity
genes are in green. Locus tags are shown for the first and last genes of each cluster, and conserved domains are indicated below the genes where relevant.
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motif and an M23 peptidase family domain, indicating that it
probably targets the PG, which is a common target for T6SS Tae
effectors (49). Furthermore, the predicted immunity protein con-
tains a signal peptide, which indicates that it interacts with an
effector targeted to the periplasm.
By our RNA-seq and differential proteomic analyses, we found
that most of the vgrG genes and their associated cluster were up-
regulated in T6A. baumannii (Table 1). The vgrG3 gene, which is
located upstream of the main T6SS cluster, was upregulated 1.8-
fold, while tse transcripts increased 9.5-fold. Similarly, transcripts
of vgrG1 and its associate tle increased 4.8- and 21.6-fold, respec-
tively. Interestingly, vgrG2 expression decreased by 1.6-fold, while
the effector and immunity genes were upregulated 2.1- and 1.6-
fold, respectively. However, expression of this cluster was robust
in both T6 and T6 cells, as assessed by counts of transcripts per
million (TPM), which suggests that the cluster containing vgrG2 is
regulated in a differentmanner.We found a significant increase in
the transcription of vgrG4 (upregulated 2.4-fold) in T6 cells;
however, the changes in the expression of the predicted down-
stream effector and immunity proteins encoded by tae and tai
(increased 1.4- and 1.8-fold, respectively) did not reach statistical
significance. Collectively, these data support the notion thatmany
of these vgrG clusters are coregulated with the core T6SS in this
organism.
With the core components of the T6SS delineated, we sought
to determine the roles of these VgrG proteins in A. baumannii
T6SS function. Using a recently described mutagenesis strategy
(50), we generated a complete series of mutants lacking one, two,
three, or all four vgrG genes in every possible combination in the
A. baumannii ATCC 17978 T6 background. These strains were
then assessed for the ability to express and secrete Hcp, as well as
the ability to kill E. coli prey cells (Fig. 3A to D). As a control for
Hcp secretion andE. coli killing, we used amutantwith a change in
the essential tssM gene that prevents apparatus assembly and
therefore T6SS-mediated bacterial killing (38).
The results of our Hcp secretion and bacterial killing experi-
FIG 3 Hcp secretion and bacterial killing by T6 A. baumanniiATCC 17978 vgrGmutants. Western blot assays probing for Hcp and RNA polymerase (RNAP)
and E. coli killing assays were performed with single vgrG deletion mutants (A), double vgrG deletion mutants (B), triple and quadruple vgrG deletion mutants
(C), and tse2 and tse3 effectormutants (D) in thevgrG34 orvgrG24 background, respectively. For the bacterial killing assay graphs, theA. baumannii predator
strains indicated are on the x axis and the log-transformed surviving E. coliMG1655R CFU count is on the y axis. A drug-sensitive strain of E. coli or no predator
(none) was used as a control. The results shown are from two independent experiments performed in triplicate. Asterisks indicate statistical significance
compared to wild-type T6 (unpaired, two-tailed Student t test; **, P 0.01).
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ments with the full suite of vgrG mutants are summarized in Ta-
ble 2. On the basis of our data, vgrG1 can be considered the most
significant contributor to Hcp secretion in T6 A. baumannii.
When vgrG1 was mutated, secretion of Hcp was impaired; in all
other single vgrG mutants, Hcp was secreted to wild-type levels
(Fig. 3A). Double vgrG mutants in which vgrG1 was deleted se-
creted markedly less Hcp than the wild type, although there were
subtle differences among the vgrG12, vgrG13, and vgrG14
mutants (Fig. 3B). The remaining double mutants, all of which
contained a functional copy of vgrG1, did not show any Hcp se-
cretion defect. Minimal amounts of Hcp were detectable in the
supernatants from the vgrG123 and vgrG134 triple mutants,
which suggests that VgrG4 or VgrG2 is required for the low levels
of Hcp secretion observed in the absence of VgrG1 (Fig. 3C). A
total lack of Hcp in supernatants from the vgrG124 mutant in-
dicated that VgrG3 does not play a role in Hcp secretion. Interest-
ingly, Hcp secretion was identical to that of wild-type bacteria in
the vgrG234 strain, which solely contains VgrG1. Expression of
VgrG1 from a plasmid in either thevgrG1 or thevgrG124 back-
ground reconstituted Hcp secretion, confirming the essential role
of VgrG1 inHcp export (see Fig. S1 in the supplementalmaterial).
As expected, no Hcp was secreted by the strain lacking all four
vgrG genes (Fig. 3C).
Assessment of antibacterial activity in the various vgrGmutant
strains revealed that deletion of vgrG1 had a small but significant
effect on E. coli survival, while the remaining single vgrGmutants
had no appreciable bacterial killing defect compared to the wild
type (Fig. 3A). This result is consistent with the Hcp secretion
defect in the vgrG1 mutant strain. Many of the double vgrG
mutants were severely impaired in the ability to kill E. coli. The
vgrG12 andvgrG13mutants were attenuated to the level of the
tssM strain, while thevgrG14mutant had a less pronounced yet
still significant defect (Fig. 3B). This result mirrors the corre-
sponding Hcp secretion phenotypes. Of the remaining double
mutants, each of which retained wild-type levels of Hcp secretion,
thevgrG23mutant was particularly defective in bacterial killing.
In fact,E. coli survived to a greater extentwhen incubatedwith this
mutant than when incubated with the tssM strain. We found a
small but statistically significant loss of bacterial killing by the
vgrG34 strain, whereas no phenotypic difference was detected
between vgrG24 mutant and wild-type bacteria. All triple mu-
tants, regardless of the combination, were unable to kill E. coli in a
T6SS-dependentmanner (Fig. 3C).Of particular note is the loss of
bacterial killing by the vgrG234 mutant strain, which was the
only triple mutant able to secrete Hcp to wild-type levels, suggest-
ing that any effectors requiring VgrG1 for export are not sufficient
to kill E. coli. Predictably, mutation of all four vgrG genes abro-
gated bacterial killing (Fig. 3C).
The above-described experiments showed that vgrG24 and
vgrG34 mutant strains retained wild-type (or nearly wild-type)
levels of Hcp secretion and antibacterial activity, while the
vgrG234 strain secreted Hcp to similar levels but was unable to
kill E. coli. This suggested that the putative effectors encoded by
genes near vgrG2 and vgrG3, Tde and Tse, respectively, may play a
key role in bacterial killing. We therefore constructed vgrG34
tde and vgrG24 tsemutants and assessed the abilities of these
strains to secreteHcp and kill E. coli.While thesemutants secreted
wild-type levels of Hcp, neither was able to kill E. coli, indicating
that Tse2 and Tse3 are important mediators of antibacterial activ-
ity (Fig. 3D). Furthermore, expression of Tdi in E. coliwas protec-
tive against killing by thevgrG34 strain, confirming Tde and Tdi
as an effector-immunity pair (see Fig. S2 in the supplemental ma-
terial).
Identificationof aPG-hydrolyzingenzymeessential forT6SS
function. While much progress has been made in understanding
the biogenesis and formation of a functional T6SS, it remains
unknownhow the assembled apparatus transits the PG layer of the
T6SS-producing organism (51). In our analysis of the A. baylyi
ADP1 T6SS, we identified ACIAD2699 as essential for Hcp secre-
tion. The homolog of this gene in A. baumannii ATCC 17978
(ACX60_11600) was coregulated with the T6SS (Table 1). This
gene encodes a protein with two predicted transmembrane do-
mains and a C-terminal peptidase domain found in the PG-
cleaving VanY peptidase superfamily of proteins (pfam13539) but
does not resemble any characterized T6SS component from other
bacteria (Fig. 4A; see Fig. S3 in the supplemental material). Anal-
ysis of protein charge distribution revealed a stretch of positive
charges directly after the first predicted transmembrane domain
and, on the basis of the “positive-inside rule,” would position the
C-terminal enzymatic domain in the periplasm (see Fig. S3) (52).
Bioinformatic searches, alignments, and in silico modeling
showed that this C-terminal domain shared metal-coordinating
and active-site residues with a Listeria phage endolysin, Ply500, an
L-alanoyl-D-glutamate endopeptidase that was previously charac-
terized and crystallized (53, 54) (Fig. 4A and B). Furthermore, this
gene is conserved in the T6SS clusters of all Acinetobacter species
and a homolog is also present in the T6SS clusters of Burkholderia
thailandensis andRalstonia solanacearum (Fig. 5A and B).We rea-
soned that this enzyme, which we have termed TagX (type VI-
associated gene X), in keeping with previous nomenclature, could
play an essential role in T6SS tubule transit through the PG layer
of T6SS-producing Acinetobacter bacteria.
We mutated the tagX homolog in A. baumannii ATCC 17978
and confirmed that this strain was unable to secrete Hcp (Fig. 6).
Importantly, Hcp secretion was restored in A. baumannii and
TABLE 2 Summary of Hcp secretion and bacterial killing data in
Fig. 3a
A. baumannii ATCC 17978 strain Hcp secretiona Bacterial killingb
T6  
T6 tssM  
T6 vgrG1  
T6 vgrG2  
T6 vgrG3  
T6 vgrG4  
T6 vgrG12  
T6 vgrG13  
T6 vgrG14  
T6 vgrG23  
T6 vgrG24  
T6 vgrG34  
T6 vgrG123  
T6 vgrG124  
T6 vgrG134  
T6 vgrG234  
T6 vgrG1234  
T6 vgrG34 tse2  
T6 vgrG24 tse3  
a Symbols:, wild type;, moderately impaired;, impaired;, severely
impaired;, not detected.
b Symbols:, wild type;, impaired;, severely impaired.
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A. baylyi tagX mutants upon expression of the respective TagX
protein from a plasmid (Fig. 6). Using the alignment against the
Ply500 PG hydrolase as a guide, we identified conserved amino
acids comprising the putative active-site and metal-coordinating
residues of TagX. We reasoned that if TagX were a PG hydrolase,
mutation of these sites would abrogate PG hydrolysis by this en-
zyme. We cloned, expressed, and purified C-terminally His-
tagged full-length TagX and a TagXmutant protein with a change
in the putative active site (TagXD287N) from E. coli (Fig. 6B; see
Fig. S4 in the supplemental material). Expression and purification
of the wild-type and TagXD287N proteins were similar. Western
blot analysis of purified TagX showed that the protein ran as two
predominant bands at a molecular mass of ~40 kDa, near the
predicted molecular mass of 36.2 kDa, and also contained a spe-
cies with a higher molecular mass of ~80 kDa, possibly a dimer.
Several degradation products that maintained anti-His reactivity
were observed when the protein was purified from E. coli without
protease inhibitors (to prevent inhibition of TagX enzymatic ac-
tivity), indicating that they contained the predicted catalytic do-
mains (Fig. 6B). Addition of protease inhibitors lacking EDTA
prevented this degradation (Fig. 6B).
To assess the ability of TagX to cleave PG, we performed PG
zymogram assays with gels impregnated with PG isolated from
A. baumannii. After the PG zymograms were renatured and
stained, only lanes containing TagX, but not TagXD287N, resulted
in clear bands of PG hydrolysis (Fig. 6B). Interestingly, of the two
predominant protein bands detected by Western blotting, only
the lower-molecular-mass species showed activity, which suggests
that the full-length enzyme is inactive. Further, despite being pres-
ent in small quantities, TagX degradation products were fully ac-
tive, degrading PG comparably to the higher-molecular-mass spe-
cies. We further assessed the stability and activity of TagX by
limited proteolysis with proteinase K (55). In these time course
experiments, the full-length enzyme was almost fully degraded by
FIG 4 The TagX protein of A. baumannii ATCC 17978. (A) At the top is a schematic of TagX showing the locations of the predicted transmembrane (TM)
domains and the pfam13539 peptidase domain, which resembles members of the VanY superfamily. At the bottom is an alignment of the A. baumannii and
A. baylyi TagX pfam13539 domains with the Listeria phage endolysin PlyA500 (accession no. AAY52812). Relevant metal-coordinating residues are indicated by
the blue arrows, and the red arrow shows the general base in the active site of the characterized Ply500 enzyme. (B, i) The crystal structure of the enzymatically
active domain Ply500 (Protein Data Bank code 2VO9) (53, 54) (left) and the modeled structure of the C-terminal end of A. baumannii TagX. The metal-
coordinating residues are red, and the general base residue is purple. (B, ii)Overlay of the crystal structure of Ply500 and themodeled structure of TagX.Modeling
was performed with SWISS-MODEL (80).
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proteinase K treatment (Fig. 6C, top). In contrast, the C-terminal
fragments were completely resistant to protease activity and accu-
mulated throughout the experiment, presumably from cleaved
full-length TagX. The accumulation of the protease-resistant
C-terminal fragment correlated with a very significant increase in
PG hydrolysis by these samples, as shown by zymogram assay
(Fig. 6C, bottom). At 60min, the C-terminal fragment was almost
exclusively present. The protein levels of full-length TagX at time
zero and the C-terminal fragment at 60 min were not markedly
different, yet the C-terminal fragment cleaved PG to a much
greater extent than full-length TagX at the respective time points.
This suggests that the C-terminal fragment displays higher enzy-
matic activity than the full-length protein and, considering its
resistance to protease digestion, suggests a possible regulatory
mechanism.
We performed protein localization studies by fractioning
A. baumannii cells expressing TagX. As predicted, TagX localized
to the inner membrane fraction (Fig. 6D) but was not detected in
the cytoplasm or outer membrane fraction. A His-tagged
C-terminal degradation product of TagX was detected in the
periplasmic fraction, which supports the prediction that the
pfam13539 domain is oriented toward the periplasm. The local-
ization of RNA polymerase (cytoplasm), PglC (inner membrane)
(56), and OmpA (outer membrane) (57) was determined as a
control for the isolation of each fraction. Although OmpA was
observed in three fractions, it was enriched in the outer mem-
brane, as expected. Additional experiments revealed that TagX
was not secreted into culture supernatants (Fig. 6E), indicating
that TagX is a bona fide structural element of the T6SS.
In order to determine its site of cleavage, we incubated purified
TagX and TagXD287N with PG from A. baumannii and performed
high-performance liquid chromatography (HPLC) and mass
spectrometry (MS) to assess cleavage products. PG incubatedwith
TagXD287N or buffer alone looked similar by HPLC (Fig. 7A).
Conversely, PG partially digested with TagX showed evidence of
degradation, with a large peak of a monomeric species eluting at
~7min. Upon complete digestion, this was the only peak remain-
ing. MS analysis of this peak showed that it was composed of the
PG fragment N-acetylglucosamine–N-acetylmuramic acid at-
tached to L-Ala, which is the first amino acid residue of the peptide
stem (Fig. 7B). These results indicate that the cleavage site of
TagX, which enzymatically acts as an L,D-endopeptidase, is be-
FIG 5 (A) Schematic of the core T6SS clusters from A. baumannii ATCC 17978, B. thailandensis E264, and R. solanacearum GMI1000. Black arrows represent
T6SS-related genes, and tagX is blue. Genes with unknown functions are gray. (B) Alignment of the full-length TagX proteins from these three bacteria with the
predicted transmembrane residues of the A. baumannii TagX underlined.
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tween the L-Ala and D-Glu residues of the PG pentapeptide
(Fig. 7B, inset).
DISCUSSION
Great strides have been made in our understanding of the func-
tion, biogenesis, and regulation of the bacterial T6SS since its for-
mal description a decade ago (10, 11). However, recent studies
have alsomade it clear that the T6SS can display variations among
different species and even among strains of a species or cells of a
population. Functionally, the T6SS can be used as an antibacterial,
antieukaryotic, or both types of weapon, depending on the organ-
ism(s) (58). While many T6SS components are conserved across
bacteria, others are species specific. Finally, a diverse range of
strategies have evolved to regulate T6SS activity among different
organisms (51, 59). For these reasons, it is important to experi-
mentally study the T6SS of the organism of choice in order to
delineate the distinctive aspects of this secretory apparatus that
may differ from those of other bacteria. Our results further em-
phasize this point, as we have shown that the T6SS ofAcinetobacter
species, while encoding many components already shown to be
important for T6SS function in other bacteria, contains several
novel genes that are essential for Hcp secretion but are not in-
FIG 6 TagX is a membrane-anchored PG hydrolase. (A) Expression and secretion of Hcp and RNA polymerase (RNAP) in pellet (P) and supernatant (S)
samples of wild-type A. baumannii (T6), the tssM mutant, the tagX mutant, the tagX mutant vector control, and the complemented tagX mutant. (B)
Expression and secretion ofHcp in P and S samples of wild-typeA. baylyi, thetagXmutant, and the complementedmutant strain. (B, left)Western blot analysis
of purified TagX, TagX plus a protease inhibitor (TagXinhibitor), and the TagXD287Nmutant protein. Proteins were detected with an anti-His polyclonal antibody.
(B, right) Zymogram assay with purified TagX proteins and lysozyme as a control. Red and green arrows indicate areas of PG degradation and the corresponding
bands in the Western blot. (C) Limited proteolysis of purified TagX. TagX was treated with proteinase K for various times (0 to 60 min), run on an SDS-PAGE
gel, and analyzed byWestern blotting (top) or loaded onto a gel impregnatedwith PG for zymogramanalysis (bottom). (D)Cellular fractionation studies of TagX
in periplasmic (Peri), cytoplasmic (Cyto), inner membrane (IM), and outer membrane (OM) fractions of A. baumannii with RNAP, PglC, and OmpA as
localization controls. (E) P and S samples of the T6 A. baumannii tagX mutant and the tagX mutant containing the control vector or expressing TagX were
analyzed by Western blotting for TagX expression. Low levels of TagX in the supernatant correspond to leakage of RNAP, indicating that some lysis occurs.
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cluded among those that encode other characterized T6SSs. Our
analysis showed that 14 genes, ACIAD2684 to ACIAD2697 and
ACIAD2699, are essential for Hcp secretion in A. baylyi. The sys-
tematic mutagenesis of the T6SS of Edwardsiella tarda, Agrobacte-
rium tumefaciens, and Vibrio cholerae has yielded important in-
sights into the core genes required for T6SS activity (32, 33, 60).
In general, our results are consistent with those of previous
studies of other bacterial species. This includes a PAAR protein
(ACIAD2681) that, when mutated by itself, has no effect on Hcp
secretion but, if mutated in combination with two other PAAR
proteins encoded by genes located elsewhere on the chromosome,
blocks T6SS (24). Most of the A. baylyi genes required for Hcp
secretion, and thus T6SS activity, are also required for T6SS in
E. tarda,V. cholerae, andA. tumefaciens. However, our analysis has
uncovered three essential T6SS genes (ACIAD2685, ACIAD2693,
and ACIAD2699) that, to our knowledge, have not previously
been implicated in T6SS activity and are conserved across Acin-
etobacter species. This indicates that these proteins play an impor-
tant role in T6SS biogenesis in this genus, but their precise roles
remain to be determined. Acinetobacter species do not produce a
readily identifiable homolog of TssJ (38), a lipoprotein required
for T6SS activity in some organisms, and thus, these proteins may
compensate for this. Mutation of the gene for ACIAD2698 in-
creased Hcp secretion, indicating that it may perform some regu-
latory function. Finally, we have identified a novel role for
ACIAD2699 (tagX), as discussed below, which highlights the im-
portance of examining individual T6SS clusters.
VgrG proteins are secreted in a T6SS-dependent manner and
can either contain toxic domains or facilitate the secretion of other
effectors (18, 25, 26). These proteins can also be essential for Hcp
secretion and thus T6SS function. In V. cholerae, mutation of
vgrG1 or vgrG2, but not vgrG3, prevents Hcp secretion (18), al-
though vgrG3 mutation results in a detectable Hcp secretion de-
fect (61). Similarly, in P. aeruginosa, vgrG1a and vgrG1c are re-
quired for efficientHcp secretion andHcpwas undetectable in the
double mutant (19). A third vgrG, vgrG1b, was dispensable for the
secretion of Hcp (19). In addition to their importance in appara-
tus assembly, it has now become apparent that many VgrG pro-
teins facilitate the secretion of cognate effectors (25, 26). Our
RNA-seq, differential proteomic, and bioinformatic analyses
identified the putative vgrG clusters in several strains of A. bau-
mannii, and although the VgrG proteins were themselves not pre-
dicted to contain effector domains, all were encoded by genes near
genes for predicted effectors with various enzymatic functions. In
A. baumannii ATCC 17978, we identified the presence of four
vgrG genes that were scattered throughout the genome. Their
proximity to proteins with predicted toxin domains suggested
that these VgrG proteins may facilitate effector secretion. While
we did not assess the secretion of these proteins in this study, our
mutational strategy showed that VgrG1 is necessary for efficient
Hcp secretion, similar to what was seen in P. aeruginosa, and de-
letion of vgrG1 resulted in a modest bacterial killing defect. Fur-
thermore, the sole presence of VgrG1 was sufficient for wild-type
levels of Hcp secretion in the vgrG234 mutant, confirming its
importance for Hcp export. Because mutation of vgrG1 affected
T6SS apparatus formation, mutants lacking this gene in combina-
tion with other vgrG genes are difficult to assess for their roles in
bacterial killing. However, our finding that several double mu-
tants (which contained a functional vgrG1 gene) lost the ability to
kill E. coli provides important insights into the roles of these other
vgrG genes in antibacterial activity. For example, thevgrG23mu-
tant secreted wild-type levels of Hcp but did not kill E. coli, which
FIG 7 TagX is an L,D-endopeptidase. (A) Chromatographic analysis by HPLC of isolated A. baumannii PG (PGAb). PG was digested with TagX, incompletely
digested with TagX, digested with TagXD287N, or left without enzyme addition. After treatment, the PG was subsequently digested with muramidase and the
resultingmuropeptides were analyzed byHPLC. Peaks corresponding to PGmonomers, dimers, trimers, and anhydromuropeptides are indicated at the top. The
asterisk indicates the peak in the TagX-digested PGAb sample that was further selected for MS characterization. (B) MS analysis of the peak selected from
the HPLC trace. Themajor peak atm/z 570 corresponds to a PGmonomer containing L-alanine. The inset shows the proposed TagX cleavage site on a PG dimer.
mDAP,meso-diaminopimelic acid.
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suggests that the presence of VgrG1 and VgrG4 is not sufficient to
kill E. coli. One hypothesis for this is that the effectors downstream
of VgrG1 and VgrG4 are not active against bacteria. Tle contains a
putative lipase, and Tge has a LysM PG-binding domain and a
peptidase domain, indicating that it acts on PG. Both lipase and
murein hydrolase effectors have been implicated in T6SS-
mediated bacterial killing (12), suggesting that Tle and Tge could
be active against E. coli. Alternatively, Tle and Tge action may not
be sufficient for a bactericidal effect. In contrast, thevgrG24 and
vgrG34 mutants secreted Hcp and killed E. coli similarly to the
wild type, which implies that effectors secreted in a VgrG2- and
VgrG3-dependent manner are important for mediating bacterial
killing. Indeed, mutation of tde or tse in these backgrounds, re-
spectively, completely abrogated killing. The genetic makeup of
the vgrG2 gene cluster, including the tde effector and tdi immunity
genes, is strikingly similar to that of the nuclease effector-
immunity pair described in A. tumefaciens, suggesting that Tde
functions as a nuclease (48). Supporting this is our finding that
E. coli was rescued from Tde killing by expression of the Tdi im-
munity protein. Despite its clear importance for antibacterial ac-
tivity, we were unable to detect any obvious toxin domains asso-
ciated with Tse, and thus, this protein may represent a new family
of T6SS-delivered toxins. One interesting finding is that signifi-
cant amounts of E. coli killing by thetssMmutant ofA. bauman-
niiATCC17978 are detected compared toE. coli controls. This has
been described previously by us and others and suggests that ad-
ditional antibacterial mechanisms exist in this strain apart from
T6SS (38, 41). Furthermore, our assays showed that several com-
binations of vgrG mutants, for example, the vgrG23 mutant,
were attenuated for E. coli killing to an even greater extent than the
tssM mutant. While the mechanistic basis of this is not known,
VgrG proteins from P. aeruginosa and Francisella tularensis have
been demonstrated to be secreted in a T6SS-independentmanner,
which may explain some of the observed T6SS-independent kill-
ing (62, 63).
Dedicated PGhydrolases are often genetically linkedwithmac-
romolecular complexes that have components that cross the PG
layer (37). Biochemically, these enzymes are frequently lytic trans-
glycosylases that cleave the glycosidic linkages of the PG disaccha-
ride backbone (64). In many cases, these hydrolases physically
interact with core components of the membrane-spanning com-
plexes, allowing them to alter the PG layer at precise cellular loca-
tions. Examples of this include VirB1 from Brucella suis, which
interacts with other VirBT4SS components; FlgJ from Salmonella,
which interacts with other flagellar components; and the lytic
transglycosylase EtgA from E. coli, which is essential for T3SSs
(65–68). Bacteriophage, although entering the cell from the exter-
nal environment, must also possess a mechanism to cross the PG
when puncturing a bacterial cell. For T4 phage, this is accom-
plished by the lysozyme domain of the gp5 protein (69). Interest-
ingly, VgrG proteins show sequence and structural homology to
gp5 but lack this lysozyme domain (17, 18, 30, 70, 71). Despite the
requirement of a PG hydrolase for these systems, an enzyme per-
forming this function for T6SS has yet to be described.Our genetic
analysis of the A. baumannii ATCC 17978 and A. baylyi ADP1
T6SS clusters identified TagX as an essential component of the
T6SS machinery, as tagX mutants failed to secrete Hcp. The
C-terminal end of TagX shares homology with enzymatically ac-
tive domains of Ply500 from Listeria monocytogenes phage A500
and CwlK from Bacillus subtilis. Both enzymes are part of the LAS
family of peptidases and are L-alanoyl-D-glutamate endopepti-
dases that cleave the PGpeptide stem (53, 54, 72). The finding that
TagX and phage protein Ply500 show sequence similarity agrees
with the evolutionary connection between T6SS and many bacte-
riophage components (17). Our experiments confirmed TagX as
an inner membrane L,D-endopeptidase requiring conserved
amino acid residues for activity located at its C-terminal end. In-
terestingly, TagX was expressed and purified as twomajor protein
bands, but only the lower-molecular-mass protein was active, in-
dicating that the full-length TagX protein lacks activity. As the
protein was expressed with a C-terminal His tag, the N-terminal
domain may possess some form of autoinhibitory activity. Auto-
inhibition of PG hydrolases has been previously demonstrated,
and thus, TagX may be regulated in a similar fashion (73). Fur-
thermore, the C-terminal end is highly resistant to proteinase K
digestion and, although the biological relevance of this is un-
known,may play a role in the regulation of TagX. It is tempting to
speculate that interaction with other components of the T6SS ap-
paratus may control the enzymatic activity of TagX, allowing for
precise spatial regulation of PGdegradation. TagX is present in the
T6SS clusters of several other organisms, includingmanyBetapro-
teobacteria, but is notably absent from other well-characterized
T6SSs, such as those of P. aeruginosa and V. cholerae. We hypoth-
esize that T6SS-producing organisms have evolved other mecha-
nisms for enabling T6SS passage through the PG layer, and there-
fore, we predict that additional enzymes playing this role remain
to be discovered.
The data presented here provide a framework and direction for
future studies of the T6SS ofAcinetobacter species.We have estab-
lished the basic requirements for elaborating a functional T6SS in
these organisms and demonstrated that VgrG proteins show
marked differences in their relative contributions toHcp secretion
and bacterial killing. Furthermore, we have delineated the roles of
a putative nuclease-immunity pair, Tde andTdi, and an effector of
unknown activity, Tse, in antibacterial activity. Our experiments
suggest that these effectors require their cognate VgrG for secre-
tion by the T6SS. Future studies on the nature of effectors secreted
by this system, as well as the basis for their secretion, should fur-
ther uncover the precise physiological role of the T6SSs in these
organisms. Finally, our discovery of TagX presents a more com-
plete picture of T6SS biogenesis and suggests that similar enzymes
should be identifiable in other organisms.
MATERIALS AND METHODS
Bacterial strains and growth conditions. For the bacterial strains and
plasmids used in this study, see Table S1 in the supplemental material.
Strains were grown in LB medium at 37°C with shaking. The antibiotics
ampicillin (50g/ml), kanamycin (50g/ml), rifampin (150g/ml), and
tetracycline (5 g/ml) were added where necessary.
RNA-seq of T6 and T6 cells. Triplicate cultures of T6 and T6
A. baumannii ATCC 17978 were grown overnight, diluted into fresh me-
dium, and grown to an optical density at 600 nm (OD600) of 0.5. Three
hundred microliters of cells was lysed, and RNA was stabilized by using
the protocols and buffers for the RNAprotect Bacteria Reagent kit
(Qiagen). RNAwas purifiedwith the RNeasyminikit (Qiagen), and rRNA
was depleted with the RiboZero kit (Illumina). Directional RNA-seq li-
braries were constructed with the PrepX RNA-Seq for Illumina library kit
(Wafergen) and sequenced with an Illumina NextSeq 500 as paired-end
75-base reads. Reads were mapped as paired ends to the A. baumannii
ATCC 17978-mff genome, raw counts and TPM values were calculated,
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and differentially expressed genes were identified with the DESeq2 pack-
age in R (74).
Sample preparation for whole-cell proteomics. Ten milligrams of
freeze-dried bacterial cellular material was suspended in 4% SDS–
100mM triethylammonium bicarbonate (TEAB; pH 8.0)–20mMdithio-
threitol and boiled at 95°C at 2,000 rpm for 10 min. Dried protein pellets
were resuspended in 6 M urea–2 M thiourea–40 mM NH4HCO3 and
reduced/alkylated prior to digestion with Lys-C (1/200, wt/wt) and then
trypsin (1/50, wt/wt) overnight as previously described (75). Digested
samples were acidified to a final concentration of 0.5% formic acid and
desalted with 50mg of tC18 SEP-PAK (Waters Corporation, Milford, CT)
according to the manufacturer’s instructions. Briefly, tC18 SEP-PAK was
conditioned with buffer B (80% acetonitrile [ACN], 0.1% formic acid)
and washed with 10 volumes of buffer A* (0.1% trifluoroacetic acid, 2%
ACN), the sample was loaded, the columnwas washed with 10 volumes of
buffer A*, and bound peptides were eluted with buffer B and then dried.
For tandem mass tag (TMT) labeling, samples were resuspended in
100 mM TEAB and 100 g of peptide according to the manufacturer’s
instructions. Samples T6B1, T6B2, T6B3, T6B1, T6B2, and T6
B3 were labeled with TMT labels 126 to 131, respectively. After being
labeled samples were pooled and C18 StAGE Tips2 was used to desalt the
peptides prior to fractionation by basic reverse-phase chromatography.
Briefly, peptides were separated with an 1100 series HPLC instrument
with a Zorbax Extend C18 column (1.0 by 50 mm, 3.5 m; Agilent) at a
flow rate of 100l/min. The following gradientwas run: initial 5min from
100%buffer A (5mMammonium formate, 2% acetonitrile, pH 10) to 6%
buffer B (5 mM ammonium formate, 90% acetonitrile, pH 10), then in
2 min to 8% buffer B, followed by an increase to 27% buffer B in 38 min,
to 31% B in 4min, to 39% B in 4min, to 60% B in 7min, and completion
with a 4-min run at 100% buffer B and a 26-min gradient back to 100%
buffer A. Fractions of 100 l were collected in a 96-well plate with every
eighth fraction combined to generate a total of eight fractions that were
concentrated by vacuum centrifugation and subjected to MS analysis.
Liquid chromatography-tandem MS (MS/MS) analysis. Purified
peptides were resuspend in buffer A* and separated on an EASY-nLC1000
system coupled to an LTQ-Orbitrap Velos (Thermo Scientific). Briefly,
samples were loaded directly onto an in-house-packed 30-cm, 75-m-
inner-diameter, 360-m-outer-diameter Reprosil-Pur C18 AQ 3 m col-
umn (Dr.Maisch, Ammerbuch-Entringen, Germany). Reverse-phase an-
alytical separation was performed at 350 nl/min over a 180-min gradient
by altering the buffer B concentration from 0 to 32% in 150 min, from 32
to 40% in the next 5 min, increasing it to 100% in 2.5 min, holding it at
100% for 2.5 min, and then dropping it to 0% for another 20 min. The
LTQ-Orbitrap Velos was operated with Xcalibur v2.2 (Thermo Scientific)
at a capillary temperature of 275°C with data-dependent acquisition and
switching between collision-induced dissociation (CID) MS/MS (nor-
malized collision energy [NCE], 35%; activation Q, 0.25; activation time,
10 ms; automated gain control [AGC] at 4  104) and higher-energy
collisional dissociation (HCD) MS/MS (resolution, 7,500; NCE, 45%;
AGC at 2e5; maximum fill time, 200 ms).
MSdata analysis.MSdatawere processedwithMaxQuant (v1.5.3.28)
(76). Database searching was carried out against the referenceA. bauman-
nii ATCC 17978 proteome (downloaded from UniProt on 16 November
2014; 3,799 proteins) and our recent resequencing genome A. baumannii
ATCC 17978-mff proteome (42) with the following search parameters:
carbamidomethylation of cysteine as a fixed modification, oxidation of
methionine, acetylation of protein N-terminal trypsin/P cleavage with a
maximum of two missed cleavages. TMT-6-based quantitation was en-
able by using the default TMT-6 settings with an MS tolerance of 6 ppm,
an HCDMS/MS tolerance of 20 ppm, a CIDMS/MS tolerance of 0.5 Da,
and a maximum false-discovery rate of 1.0% for protein and peptide
identifications. The resulting protein group output was processed within
the Perseus (v1.5.0.9) analysis environment to remove reverse matches
and common protein contaminants.
Hcp secretion and bacterial killing. Detection of Hcp in normalized
samples of whole cells and culture supernatants by Western blotting was
performed as described previously, with an anti-Hcp and anti-RNA poly-
merase antibody, which was used as a lysis control (BioLegend) (42).
Except where indicated otherwise, samples were collected from cells
grown for 4 h after 1:50 back dilution into fresh medium after overnight
growth. Detection of Hcp in strains complemented with the VgrG1-
expressing plasmids was done after overnight growth.
Bacterial killing assays were performed as follows. Cultures of A. bau-
mannii and E. coli MG1655R were grown overnight, and the E. coli cells
were washed three times with fresh LB to remove rifampin. The cells were
then resuspended to anOD600 of 1.0, 100l ofE. coliwasmixedwith 10l
ofA. baumannii, and a 10-l sample was spotted onto a dry LB agar plate.
After a 4-h incubation at 37°C, spots were cut from the agar and resus-
pended by mixing with 500 l of LB broth. This mixture was serially
diluted 10-fold, and dilutions were plated onto rifampin-containing LB
agar to determine the number of E. coli CFU remaining. Controls con-
sisted of E. coliMG1655Rmixed with rifampin-sensitive E. coli TOP10 or
LB medium. Experiments were performed twice in technical triplicate.
For analysis of Tsi2, experiments were performed as described above but
with a tetracycline-resistant E. coli strain either containing a pEXT20 con-
trol vector or expressing pTdi. Competitions for these experiments were
done at a 1:20 A. baumannii-to-E. coli ratio, and E. coli bacteria were
enumerated on agar plates containing tetracycline.
Construction ofA. baumanniimutants, cloning, andWestern blot-
ting. For the primers used in this study, see Table S2 in the supplemental
material. Mutants were constructed as described previously (50). Briefly,
an antibiotic resistance cassette was amplified with ~110-bp oligonucleo-
tide primers (Integrated DNATechnologies) with homology to the flank-
ing regions of the targeted gene with an additional 3= 18 to 25 nucleotides
of homology to the FRT site-flanked kanamycin resistance cassette from
plasmid pKD4. This PCRproductwas electroporated into competent T6
A. baumannii ATCC 17978 carrying pAT04, which expresses The RecAb
recombinase. Mutants were selected on 7.5 g/ml kanamycin, and inte-
gration of the resistance marker was confirmed by PCR. To remove the
kanamycin resistance cassette, electrocompetent mutants were trans-
formed with pAT03, which expresses the FLP recombinase, to remove the
FRT-flanked resistance cassette. Additional mutations were made by re-
peating this process, and PCR and sequencing were used to confirm the
validity of all of the mutants.
The vgrG1 gene from A. baumannii ATCC 17978 was cloned with a
10-His tag into the BamHI and PstI sites of pBAVMCS with primers
vgrG1FwdBamHI and vgrG1RevPstI10His. The tagX gene from A. baylyi
was cloned into the PacI and NotI sites of the pEVL174 vector (43) with
primers ACIAD2699-pacI and ACIAD2699-notI, and the tagX gene from
A. baumannii ATCC 17978 was cloned into the BamHI and SalI sites of
pEXT20 with primers tagXFwdBamHI and tagXFwdSalI. This construct
was used as a template for point mutations. Cloning of the A. baumannii
tagX gene into expression vector pBAVMCS was performed with primers
tagXpromFwdPstI and tagXRevPstI6His with the pTagX vector used as a
template in order to maintain the pEXT20 promoter for constitutive ex-
pression. The tdi gene was cloned into the KpnI/SalI sites of pEXT20 with
a C-terminal FLAG tag with primers tdiFwd and tdiRev. Expression of
proteins was confirmed by Western blotting with rabbit polyclonal anti-
His (Pierce) and anti-FLAG (Sigma) antibodies. Detection of primary
antibodies was done with fluorescent secondary antibodies as previously
described (38).
Pointmutations.TheQuikChange site-directedmutagenesis strategy
was utilized tomake the TagXpointmutants. Briefly, the pEXT20 plasmid
containing the 6His-tagged version of TagXwas used as the template for
the PCR. Complementary oligonucleotides containing the desired muta-
tion were used as primers, and Pfu turbo was utilized for the extension
reaction. After completion of the PCR, the products were digested with
DpnI to degrade the template DNA and then transformed into TOP10
cells. Sequencing was used to confirm mutations.
Genetic Dissection of Acinetobacter T6SS
September/October 2016 Volume 7 Issue 5 e01253-16 ® mbio.asm.org 13
Purification of TagX and point mutant TagX proteins. Overnight
cultures of BL21 cells bearing the pEXT20 plasmid with TagX containing
a C-terminal 6His tag were back diluted 1:100 into 1 liter of Luria broth
and grown at 37°C to an OD600 of ~0.6. The cultures were induced with
1 mM isopropyl--D-thiogalactopyranoside for 3 h, and the cells were
collected by centrifugation at 5,000 g for 10 min at 4ºC. The cells were
resuspended in purification buffer (25 mM Tris [pH 7.5], 200 mMNaCl,
10% glycerol) and lysed, and cell debris was removed by low-speed cen-
trifugation. The supernatant was collected, and membranes were isolated
by ultracentrifugation at 100,000  g for 1 h. The supernatant was re-
moved, and membranes were solubilized in resuspension buffer (purifi-
cation buffer plus 2%Triton X-100) to extract TagX from themembrane.
The solution was ultracentrifuged again to remove the extracted mem-
branes, and the supernatant was loaded onto an Ni-nitrilotriacetic acid
agarose column, washed with purification buffer and buffer supple-
mented with 10 and 40 mM imidazole, and eluted with buffer supple-
mented with 300 mM imidazole.
Purification of PG and zymogram assays. PG was isolated from
A. baumannii ATCC 17978 as described by Hoyle and Beveridge (77).
After inoculation into 1-liter cultures and growth overnight, cells were
pelleted, resuspended in water at a density of 200 g/liter, and then added
dropwise to an equal volume of boiling 8% SDS. Once all of the cell
suspension was added, the mixture was boiled for 3 h and then ultracen-
trifuged at 100,000 g for 1 h at room temperature to pellet the PG. The
supernatant was removed, and the pellet was washed five times with de-
ionized water to remove residual SDS. The washed PG was lyophilized
overnight until dry and then weighed to determine the yield. Purified
TagX samples resuspended in 2 Laemmli buffer were separated by 12%
bis-Tris SDS-PAGE containing 0.1% (wt/vol) PG and then washed with
water for 1 h at room temperature with multiple changes of the water in
order to remove residual SDS. The gel was then equilibrated in renatur-
ation buffer (10mMTris-HCl [pH 7], 0.1%Triton X-100, 10mMZnCl2)
for 1 h; this was followed by the addition of fresh buffer and incubation at
37°C with agitation. Water was used to wash the gel, methylene blue stain
(0.1%methylene blue, 0.01%KOH)was added, and the gel was incubated
for 1 h. Water washes were used to destain the gel until the bands of
degraded PG were visible.
Limited proteolysis of TagX. Samples of purifiedTagX in purification
buffer at a concentration of 15 Mwere digested with proteinase K (200-
g/ml final concentration) on ice. The reaction was quenched after 0.25,
0.5, 0.75, 1, 2.5, 5, 10, 15, 20, 30, 40, 50, or 60 min by adding 5 mM
phenylmethylsulfonyl fluoride (PMSF) and 1 SDS-PAGE loading buf-
fer. A control samplewas added to 5mMPMSF and 1 SDS-PAGEbuffer
before the addition of proteinase K. Once the digestion was complete, the
samples were analyzed byWestern blot and zymogram assays as described
above.
Cellular localization of TagX. Overnight cultures of A. baumannii
ATCC 17978 cells expressing TagX from pBAVMCS were diluted 1:100
and grown until anOD600 of 0.6 was reached. The cells were then pelleted,
and cell fractionation was performed as described by Luckett et al. (78),
with minor modifications. Briefly, the cells were washed three times, re-
suspended in 25 mM Tris (pH 7.4)—1 mM EDTA—20% sucrose, and
then incubated for 10min. Lysozymewas added at a final concentration of
1 mg/ml to the sample used for membrane fractions to increase the effi-
ciency of cell lysis. After centrifugation, the pellet was resuspended in 0.5
mM magnesium sulfate and incubated on ice for 10 min. For soluble
fractionation, the sample was centrifuged to obtain the periplasmic frac-
tion (supernatant). The pellet was resuspended in 25 mM Tris (pH 7.4)
and freeze-thawed, magnesium chloride and DNase were added, and the
mixture was incubated at 37°C for 15min. Centrifugationwas performed,
and the supernatant, containing the cytoplasmic fraction, was collected.
To obtain the membrane fractions, the sample was freeze-thawed and
then centrifuged to remove unlysed cells. The supernatant was transferred
to a fresh tube and centrifuged at 150,000 g to isolate total membranes.
The pellet was resuspended in 0.7% sodium lauryl sarcosine to extract
innermembrane proteins. After ultracentrifugation, the supernatant con-
tained the inner membrane fraction and the pellet, containing the outer
membrane fraction, was resuspended in 25 mMTris (pH 7.4). Trichloro-
acetic acid precipitation of all samples was performed, followed by SDS-
PAGE andWestern blot analysis by probing with antibodies to RNApoly-
merase, the 6His tag (TagX and PglC), and OmpA (79).
Analysis ofmuropeptides. Purified PG or PG digested with TagXwas
suspended in 10 ml of 10 mM Tris-HCl (pH 7.2) and digested with
100 mg/liter -amylase (Sigma-Aldrich, St. Louis, MO) for 1 h at 37°C.
This was followed by digestion with 100 mg/liter preactivated pronase E
(Merck, Darmstadt, Germany) at 60°C for 90 min. Amylase and pronase
were inactivated by boiling for 20 min in 1% SDS, and the PG was col-
lected and washed as described above for purification. The collected PG
was digested with 100 g/ml cellosyl muramidase (Hoechst AG, Frankfurt,
Germany) in 50 mM phosphate buffer (pH 4.9) at 37°C for 16 h. The
enzyme was inactivated by being boiled for 10 min in a water bath and
then centrifuged at 14,000 rpm for 5 min to remove insoluble debris. The
supernatant was mixed with 1/5 volume of 0.5 M sodium borate buffer
(pH 9.0) and reduced with excess sodium borohydride (NaBH4) for
30 min at room temperature. The pH was measured with indicator strips
(Acilit; Merck) and adjusted to 3.0 with orthophosphoric acid. The sam-
ples were filtered (Millex-GVfilters, 0.22-mpore size, 2.5-mmdiameter;
Millipore, Cork, Ireland) and injected into the HPLC column. Separa-
tions were performed on a Breeze 2 HPLC system consisting of a 1525
binary HPLC pump (model code 5CH; Waters), a 2489 UV-visible light
detector (Waters), a model 7725i manual injector (Rheodyne), and an
Aeris Peptide XB-C18, 3.6 m, 250- by 4.6-mm reverse-phase column
(Phenomenex). The column was equilibrated at 45°C, and separation of
individual muropeptides (detection wavelength of 204 nm) was per-
formed in a linear gradient. The mobile-phase (A, 50 mM sodium phos-
phate [pH 4.35]; B, 75 mM sodium phosphate, 15%methanol [pH 4.95])
gradient consisted of elution at 1.0 ml/min with 100% A for 5 min, fol-
lowed by a 60-min linear gradient to 0% A–100% B and then 100% B for
5 min.
Molecularmass analysis of isolatedmuropeptides byMSwith amodel
LTQ-Velos linear ion trap from Thermo-Scientific was carried out in the
CBMSO Protein Chemistry Facility, which belongs to the ProteoRed net-
work, PRB2-ISCIII.
Accession number(s). All of the RNA-seq data obtained in this study
are available in the NCBI Sequence Read Archive under the BioProject
identifier PRJNA288605. RNA-seq data were deposited in the NCBI
Short Read Archive and assigned accession numbers SRR3017659,
SRR3017662, SRR3017665, SRR3017667, SRR3017669, and SRR3017671.
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